Хайлтын үр дүнгүүд - Small, Eric J
- 106-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809 -н Hurwitz, Mark D., Halabi, Susan, Archer, Laura, McGinnis, Lamar S., Kuettel, Michael R., DiBiase, Steven J., Small, Eric J.
Хэвлэсэн 2011текст -
11
CTLA4 blockade expands FoxP3(+) regulatory and activated effector CD4(+) T cells in a dose-dependent fashion -н Kavanagh, Brian, O'Brien, Shaun, Lee, David, Hou, Yafei, Weinberg, Vivian, Rini, Brian, Allison, James P., Small, Eric J., Fong, Lawrence
Хэвлэсэн 2008текст -
12
Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy -н Halabi, Susan, Armstrong, Andrew J., Sartor, Oliver, de Bono, Johann, Kaplan, Ellen, Lin, Chen-Yen, Solomon, Nicole C., Small, Eric J.
Хэвлэсэн 2013текст -
13
Pre-existing levels of CD4 T cells expressing PD-1 are related to overall survival in prostate cancer patients treated with ipilimumab -н Kwek, Serena S., Lewis, Jera, Zhang, Li, Weinberg, Vivian, Greaney, Samantha, Harzstark, Andrea, Lin, Amy, Ryan, Charles, Small, Eric J., Fong, Lawrence
Хэвлэсэн 2015текст -
14
Androgen Decline and Survival During Docetaxel Therapy in metastatic Castration Resistant Prostate Cancer (mCRPC) -н Ryan, Charles J, Dutta, Sandipan, Kelly, William K, Russell, Carly, Small, Eric J., Morris, Michael J., Taplin, Mary-Ellen, Halabi, Susan
Хэвлэсэн 2019текст -
15
A PHASE II STUDY OF ESTRAMUSTINE, DOCETAXEL, AND BEVACIZUMAB IN MEN WITH CASTRATE RESISTANT PROSTATE CANCER: RESULTS OF CANCER AND LEUKEMIA GROUP B (CALGB) 90006 -н Picus, Joel, Halabi, Susan, Kelly, W. Kevin, Vogelzang, Nicholas J., Whang, Young E., Kaplan, Ellen B., Stadler, Walter M., Small, Eric J.
Хэвлэсэн 2010текст -
16
Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer -н Halabi, Susan, Lin, Chen-Yen, Kelly, W. Kevin, Fizazi, Karim S., Moul, Judd W., Kaplan, Ellen B., Morris, Michael J., Small, Eric J.
Хэвлэсэн 2014текст -
17
Optimal MRI sequences for (68)Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer -н Lake, Spencer T., Greene, Kirsten L., Westphalen, Antonio C., Behr, Spencer C., Zagoria, Ronald, Small, Eric J., Carroll, Peter R., Hope, Thomas A.
Хэвлэсэн 2017текст -
18
A bilingual, Internet-based, targeted advertising campaign for prostate cancer clinical trials: Assessing the feasibility, acceptability, and efficacy of a novel recruitment strate... -н Kaplan, Celia P., Siegel, Adam, Leykin, Yan, Palmer, Nynikka R., Borno, Hala, Bielenberg, Jessica, Livaudais-Toman, Jennifer, Ryan, Charles, Small, Eric J.
Хэвлэсэн 2018текст -
19
Baseline testosterone levels in men with clinically localized high-risk prostate cancer treated with radical prostatectomy with or without neoadjuvant chemohormonal therapy (Allian... -н Eastham, James A., Heller, Glenn, Hillman, David W., Hahn, Olwen M., Parsons, J. Kellogg, Mohler, James L., Small, Eric J., Morris, Michael
Хэвлэсэн 2021текст -
20
Mobile Clinical Trial Matching Technology in Medical Oncology Clinic: A Pilot Feasibility Study -н Borno, Hala T., Zhang, Li, Zhang, Sylvia, Kaplan, Celia, Palmer, Nynikka R., Bell, Alexander, Bakke, Brian, Lin, Amy, Aggarwal, Rahul, Small, Eric J.
Хэвлэсэн 2022текст